Ultracaine® is a dental anesthetic designed specifically for dentistry. HANSAmed Limited is proud to offer this trusted solution to dental professionals across Canada.

Ultracaine® is available in articaine hydrochloride 4% with epinephrine formulations for dental use.
Please refer to the official product information and applicable prescribing guidance for formulation details, indications, contraindications, and precautions.
Ultracaine® has a history of use in dental anesthesia. Explore the Ultracaine® brochure for additional information about the product, its history, and its role in dentistry.
Learn more about Ultracaine® manufacturing and product information in the available brochure.
Ultracaine® is formulated for use in dentistry. Dental professionals should consult the product labeling for complete information about its appropriate use.
Effective local anesthesia is an important part of dental care. Dental professionals select the appropriate anesthetic based on the procedure, patient needs, medical history, and product labeling.
For detailed product information, consult the Ultracaine® brochure and the applicable prescribing information.

Canada's Special Access Program (SAP) allows healthcare practitioners to request access to certain drugs that are not authorized for sale in Canada when the program's eligibility requirements are met. Access is subject to Health Canada's requirements and authorization process.
For current eligibility criteria and application details, consult Health Canada's official Special Access Program guidance.
Explore the Ultracaine® brochure in English or French for more information.